このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Test Anxiety on Bowel Health and Constipation in Students

2026年6月17日 更新者:Demet Öztürk、Lokman Hekim University

The Effect of Test Anxiety on Bowel Health and Constipation in University Students

This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period.

Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded.

The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.

調査の概要

状態

募集

詳細な説明

Constipation is a common gastrointestinal problem that may affect quality of life, daily activities, and psychosocial well-being. University students may be particularly vulnerable to bowel habit changes during examination periods because of increased academic stress and test-related anxiety.

This study is designed as an observational, cross-sectional, and analytical study. It will evaluate whether test anxiety is associated with bowel health indicators and constipation among university students during the final examination period. The study will be conducted at Lokman Hekim University with undergraduate students from the Department of Physiotherapy and Rehabilitation.

After providing informed consent, participants will complete self-report forms and questionnaires in a single face-to-face assessment session. The assessment will include questions about sociodemographic characteristics, bowel habits, bowel-related symptoms, constipation status, stool form, constipation severity, and test anxiety level. No intervention, treatment, randomization, or follow-up assessment will be performed.

The study is expected to provide information about the possible relationship between psychological stress related to examinations and bowel health in university students. The findings may contribute to a better understanding of stress-related bowel problems and may support future preventive approaches for young adults.

研究の種類

観察的

入学 (推定)

200

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

サンプリング方法

非確率サンプル

調査対象母集団

The study population will include undergraduate Physiotherapy and Rehabilitation students at Lokman Hekim University who are in their final examination period during the data collection process. Eligible participants will be 18 years of age or older, able to read and complete the self-report questionnaires independently, and willing to provide written informed consent.

説明

Inclusion Criteria:

  • Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University
  • Being in the final examination period during the data collection process
  • Having sufficient reading and comprehension skills to complete the questionnaires independently
  • Voluntarily agreeing to participate in the study after reading and signing the informed consent form

Exclusion Criteria:

  • Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery
  • Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease
  • Regular use of laxatives or medications that directly affect bowel movements, such as opioids
  • Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury
  • Having had an acute gastrointestinal infection within the last month

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
University Students
Undergraduate students aged 18 years and older who are studying in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University and who are in their final examination period. Participants will complete self-report questionnaires assessing test anxiety, bowel habits, stool form, constipation status, and constipation severity during a single face-to-face assessment session.
参加者は評価フォームと日記を記入しました。 介入は行われませんでした。

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Constipation Status Assessed by the Rome IV Criteria
時間枠:Baseline (Day 1)
Constipation status will be assessed using the Rome IV criteria. This outcome will be reported as a binary classification: presence or absence of constipation. Participants will be classified as having constipation or not having constipation according to constipation-related symptoms, including reduced stool frequency, straining, hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, and need for manual maneuvers. The Rome IV criteria will not be reported as a scale score.
Baseline (Day 1)

二次結果の測定

結果測定
メジャーの説明
時間枠
Constipation Severity Assessed by the Constipation Severity Instrument
時間枠:Baseline (Day 1)
Constipation severity will be assessed using the Constipation Severity Instrument. The scale includes 16 items and evaluates constipation-related symptoms across three subdomains: obstructive defecation, colonic inertia, and pain. The total score ranges from 0 to 73, with higher scores indicating more severe constipation symptoms.
Baseline (Day 1)
Stool Form Assessed by the Bristol Stool Scale
時間枠:Baseline (Day 1)
Stool form will be assessed using the Bristol Stool Scale. The Bristol Stool Scale is a 7-point stool form classification scale ranging from Type 1 to Type 7. Type 1 indicates separate hard lumps, and Type 7 indicates watery stool with no solid pieces. Higher scores do not indicate a better or worse outcome; lower scores generally indicate harder stool forms, while higher scores indicate looser stool forms. Participants will be asked to select the stool type that best represents their most common stool form during the last week.
Baseline (Day 1)
Test Anxiety Level Assessed by the Test Anxiety Inventory
時間枠:Baseline (Day 1)
Test anxiety level will be assessed using the Test Anxiety Inventory. The scale consists of 20 self-report items evaluating cognitive, emotional, and physiological symptoms of anxiety experienced before and during examinations. Total scores range from 20 to 80, with higher scores indicating higher test anxiety.
Baseline (Day 1)
Bowel Habits and Bowel-Related Symptoms
時間枠:Baseline (Day 1)
Bowel habits and bowel-related symptoms will be assessed using a researcher-developed evaluation form. The form includes questions about stool frequency, postponement of defecation, perceived bowel health, preferred toilet type, and symptoms such as abdominal pain, bloating, gas, diarrhea, nausea, vomiting, indigestion, and constipation during the last week.
Baseline (Day 1)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年2月25日

一次修了 (推定)

2026年8月25日

研究の完了 (推定)

2027年2月25日

試験登録日

最初に提出

2026年6月12日

QC基準を満たした最初の提出物

2026年6月12日

最初の投稿 (実際)

2026年6月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月22日

QC基準を満たした最後の更新が送信されました

2026年6月17日

最終確認日

2026年2月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する